• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工抗原呈递细胞拓扑结构决定 T 细胞激活。

Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation.

机构信息

Bio-Organic Chemistry, Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands.

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

出版信息

ACS Nano. 2022 Sep 27;16(9):15072-15085. doi: 10.1021/acsnano.2c06211. Epub 2022 Aug 15.

DOI:10.1021/acsnano.2c06211
PMID:35969506
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9527792/
Abstract

Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to activate T cells or , offer an effective alternative to cellular immunotherapies. However, comprehensive studies that delineate the effect of nano-aAPC topology, including nanoparticle morphology and ligand density, are lacking. Here, we systematically studied the topological effects of polymersome-based aAPCs on T cell activation. We employed an aAPC library created from biodegradable poly(ethylene glycol)--poly(d,l-lactide) (PEG-PDLLA) polymersomes with spherical or tubular shape and variable sizes, which were functionalized with αCD3 and αCD28 antibodies at controlled densities. Our results indicate that high ligand density leads to enhancement in T cell activation, which can be further augmented by employing polymersomes with larger size. At low ligand density, the effect of both polymersome shape and size was more pronounced, showing that large elongated polymersomes better activate T cells compared to their spherical or smaller counterparts. This study demonstrates the capacity of polymersomes as aAPCs and highlights the role of topology for their rational design.

摘要

纳米级人工抗原呈递细胞(aAPCs)是一种模拟免疫细胞的合成物,旨在激活 T 细胞,为细胞免疫疗法提供了有效的替代方法。然而,目前缺乏全面研究纳米 aAPC 拓扑结构(包括纳米颗粒形态和配体密度)的影响。在这里,我们系统地研究了基于聚合物囊泡的 aAPCs 对 T 细胞激活的拓扑效应。我们使用由可生物降解的聚乙二醇-聚(D,L-丙交酯)(PEG-PDLLA)聚合物囊泡制成的 aAPC 文库,这些囊泡具有球形或管状形状和不同的尺寸,并以可控的密度功能化αCD3 和 αCD28 抗体。我们的结果表明,高配体密度会增强 T 细胞的激活,而使用较大尺寸的聚合物囊泡则可以进一步增强这种效果。在低配体密度下,聚合物囊泡的形状和尺寸的影响更为明显,表明大的长形聚合物囊泡比其球形或较小的对应物更能激活 T 细胞。这项研究展示了聚合物囊泡作为 aAPCs 的潜力,并强调了拓扑结构在其合理设计中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/9127dac9eff4/nn2c06211_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/317c0e5f43fb/nn2c06211_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/c0b3152b53f6/nn2c06211_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/107eaba7cc75/nn2c06211_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/34ab9d51018f/nn2c06211_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/7c1300cf8379/nn2c06211_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/9127dac9eff4/nn2c06211_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/317c0e5f43fb/nn2c06211_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/c0b3152b53f6/nn2c06211_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/107eaba7cc75/nn2c06211_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/34ab9d51018f/nn2c06211_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/7c1300cf8379/nn2c06211_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/9527792/9127dac9eff4/nn2c06211_0006.jpg

相似文献

1
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation.人工抗原呈递细胞拓扑结构决定 T 细胞激活。
ACS Nano. 2022 Sep 27;16(9):15072-15085. doi: 10.1021/acsnano.2c06211. Epub 2022 Aug 15.
2
PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.聚乙二醇化和 CD47 偶联的纳米椭圆人工抗原呈递细胞最大限度地减少吞噬作用,并增强抗肿瘤 T 细胞反应。
Int J Nanomedicine. 2019 Apr 8;14:2465-2483. doi: 10.2147/IJN.S195828. eCollection 2019.
3
Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.基于生物学原理设计的纳米颗粒人工抗原呈递细胞用于免疫调节。
Nano Lett. 2017 Nov 8;17(11):7045-7054. doi: 10.1021/acs.nanolett.7b03734. Epub 2017 Oct 10.
4
Nanoscale artificial antigen presenting cells for cancer immunotherapy.用于癌症免疫治疗的纳米级人工抗原呈递细胞。
Mol Immunol. 2018 Jun;98:13-18. doi: 10.1016/j.molimm.2018.02.016. Epub 2018 Mar 7.
5
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.形状很重要:用于癌症免疫治疗的可生物降解各向异性纳米颗粒人工抗原呈递细胞。
Acta Biomater. 2023 Apr 1;160:187-197. doi: 10.1016/j.actbio.2023.02.023. Epub 2023 Feb 21.
6
Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.基于粒子的人工抗原呈递细胞系统在过继性 T 细胞治疗中用于 T 细胞的激活。
ACS Nano. 2024 Mar 26;18(12):8571-8599. doi: 10.1021/acsnano.3c10180. Epub 2024 Mar 14.
7
Cell-Sized Lipid Vesicles as Artificial Antigen-Presenting Cells for Antigen-Specific T Cell Activation.细胞大小的脂质囊泡作为人工抗原呈递细胞,用于抗原特异性 T 细胞激活。
Adv Healthc Mater. 2023 May;12(12):e2203163. doi: 10.1002/adhm.202203163. Epub 2023 Jan 31.
8
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.人工抗原呈递细胞对 CD8+T 细胞激活的颗粒形状依赖性。
Biomaterials. 2014 Jan;35(1):269-277. doi: 10.1016/j.biomaterials.2013.09.050. Epub 2013 Oct 5.
9
Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.可生物降解的阳离子聚合物共混物用于制备增强的人工抗原呈递细胞以治疗黑色素瘤。
ACS Appl Mater Interfaces. 2021 Feb 24;13(7):7913-7923. doi: 10.1021/acsami.0c19955. Epub 2021 Feb 12.
10
DNA origami-based artificial antigen-presenting cells for adoptive T cell therapy.基于 DNA 折纸术的人工抗原呈递细胞用于过继性 T 细胞治疗。
Sci Adv. 2022 Dec 2;8(48):eadd1106. doi: 10.1126/sciadv.add1106.

引用本文的文献

1
Smart CAR-T Nanosymbionts: archetypes and proto-models.智能嵌合抗原受体T细胞纳米共生体:原型与原始模型
Front Immunol. 2025 Aug 12;16:1635159. doi: 10.3389/fimmu.2025.1635159. eCollection 2025.
2
Diatom-Based Artificial Antigen-Presenting Cells: A Novel Approach for Adaptive Immune Modulation.基于硅藻的人工抗原呈递细胞:一种适应性免疫调节的新方法。
ACS Appl Mater Interfaces. 2025 Jul 2;17(26):37718-37734. doi: 10.1021/acsami.5c07766. Epub 2025 Jun 18.
3
Polymeric Nanoarchitectures: Advanced Cargo Systems for Biological Applications.

本文引用的文献

1
Second Near-Infrared Light-Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy.近红外二区光激活聚合物纳米拮抗剂用于光热免疫代谢癌症治疗。
Adv Mater. 2021 Sep;33(36):e2101410. doi: 10.1002/adma.202101410. Epub 2021 Jul 23.
2
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy.用于光免疫代谢癌症治疗的半导体聚合物纳米-PROTACs。
Nat Commun. 2021 May 18;12(1):2934. doi: 10.1038/s41467-021-23194-w.
3
Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
聚合物纳米结构:用于生物应用的先进载药系统
Macromol Biosci. 2025 May;25(5):e2400540. doi: 10.1002/mabi.202400540. Epub 2025 Jan 21.
4
Emerging approaches for T cell-stimulating platform development.T细胞刺激平台开发的新兴方法。
Cell Syst. 2024 Dec 18;15(12):1198-1208. doi: 10.1016/j.cels.2024.11.007.
5
CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad.嵌合抗原受体T细胞纳米共生体:揭示一种新型二元组合的无限潜力。
Int J Mol Sci. 2024 Dec 7;25(23):13157. doi: 10.3390/ijms252313157.
6
Cell surface morphology mimicking nano-bio platform for immune cell stimulation.用于免疫细胞刺激的模拟细胞表面形态的纳米生物平台。
iScience. 2024 Sep 26;27(11):111033. doi: 10.1016/j.isci.2024.111033. eCollection 2024 Nov 15.
7
Bridging the antigen-presentation gap for adoptive cell therapies.弥合过继性细胞疗法的抗原呈递差距。
Mol Ther Oncol. 2024 Sep 26;32(4):200877. doi: 10.1016/j.omton.2024.200877. eCollection 2024 Dec 19.
8
Artificial antigen-presenting cell system reveals CD28's role in modulating T cell functions during human immunodeficiency virus infection.人工抗原呈递细胞系统揭示了CD28在人类免疫缺陷病毒感染期间调节T细胞功能中的作用。
iScience. 2024 Sep 13;27(10):110947. doi: 10.1016/j.isci.2024.110947. eCollection 2024 Oct 18.
9
Engineering Functional Particles to Modulate T Cell Responses.工程化功能性颗粒以调节T细胞反应。
Acc Mater Res. 2024 Jul 18;5(9):1048-1058. doi: 10.1021/accountsmr.4c00105. eCollection 2024 Sep 27.
10
Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy.免疫调节纳米颗粒激活细胞毒性 T 细胞,增强癌症免疫疗法的效果。
Nanoscale. 2024 Oct 3;16(38):17699-17722. doi: 10.1039/d4nr01780c.
可生物降解的阳离子聚合物共混物用于制备增强的人工抗原呈递细胞以治疗黑色素瘤。
ACS Appl Mater Interfaces. 2021 Feb 24;13(7):7913-7923. doi: 10.1021/acsami.0c19955. Epub 2021 Feb 12.
4
Nanomaterials for T-cell cancer immunotherapy.用于 T 细胞癌症免疫疗法的纳米材料。
Nat Nanotechnol. 2021 Jan;16(1):25-36. doi: 10.1038/s41565-020-00822-y. Epub 2021 Jan 12.
5
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.用于增强癌症免疫疗法中抗原特异性 T 细胞扩增的生物材料。
Biomaterials. 2021 Jan;268:120584. doi: 10.1016/j.biomaterials.2020.120584. Epub 2020 Dec 5.
6
Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cells.用于高通量扩增和检测抗原特异性 T 细胞的自适应纳米颗粒平台。
Nano Lett. 2020 Sep 9;20(9):6289-6298. doi: 10.1021/acs.nanolett.0c01511. Epub 2020 Jun 28.
7
Molecular and nanoengineering approaches towards activatable cancer immunotherapy.分子和纳米工程方法在可激活癌症免疫治疗中的应用。
Chem Soc Rev. 2020 Jul 6;49(13):4234-4253. doi: 10.1039/c9cs00773c.
8
A guide to cancer immunotherapy: from T cell basic science to clinical practice.癌症免疫疗法指南:从 T 细胞基础科学到临床实践。
Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20.
9
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.利用纳米医学提高癌症免疫疗法的疗效:进展、机遇与挑战。
Nat Rev Clin Oncol. 2020 Apr;17(4):251-266. doi: 10.1038/s41571-019-0308-z. Epub 2020 Feb 7.
10
Enhancing cancer immunotherapy with nanomedicine.纳米医学增强癌症免疫疗法。
Nat Rev Immunol. 2020 May;20(5):321-334. doi: 10.1038/s41577-019-0269-6. Epub 2020 Jan 31.